NeoGenomics Reports Revenue of $121 Million in the Third Quarter

Third-Quarter 2021 Results and Highlights:Consolidated revenue of $121 million, comprised of Clinical Services revenue of $102 million and Pharma Services revenue of $19 millionConsolidated revenue decreased 3% due to the discontinuation of prior …